Xpress Biologics
PRIVATE
STATUS
1-10
EMPLOYEES
Early Stage VC
LATEST DEAL TYPE
$715K
LATEST DEAL AMOUNT
2
INVESTORS
Description
Operator of a contract manufacturing organization designed to provide services for pre-clinical productions. The company's manufacturing organization provides contract services for the production of recombinant proteins, antibody fragments and plasmid DNA, enabling the vaccine, therapeutic and diagnostic markets to execute and manage clinical trials.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
- Accessia Pharma site
- Avenue du Parc Industriel, 89, Milmort
- 4041 Herstal
- Belgium
+32 04 000 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Xpress Biologics’s full profile, request a free trial.
Xpress Biologics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 22-Dec-2016 | $715K | 00.000 | 00.000 | Completed | Generating Revenue |
| 2. Early Stage VC | 14-Aug-2015 | 00000 | 00000 | 00000 | Completed | Generating Revenue |
| 1. Accelerator/Incubator | 01-Feb-2013 | Completed | Startup |
Xpress Biologics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Class C | 0,000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | ||
| Class B | 0,000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | ||
| Class A | 000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | ||
| Class C | 000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | ||
| Class B | 1,300 | $105.64 | $105.64 | 1x | $105.64 | 9.26% | ||
| Class A | 1,211 | $105.64 | $105.64 | 1x | $105.64 | 8.63% |
Xpress Biologics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Noshaq | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| WBC | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |
Xpress Biologics Executive Team (3)
Xpress Biologics Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Christian Rodriguez Ph.D | Xpress Biologics | Co-Founder, Operation Director & Board Member | 000 0000 | |
| Philippe Ledent Ph.D | Xpress Biologics | Board Member & Scientific Director | 000 0000 |